Kidney transplantation in highly sensitized recipients
In kidney transplantation (KT), overcoming donor shortage is particularly challenging in patients with preexisting donor-specific antibodies (DSAs) against human leukocyte antigen (HLA), called HLA-incompatible KT (HLAi KT), carrying the risk of rejection and allograft loss. Thus, it is necessary to...
Main Authors: | Yohan Park, Eun Jeong Ko, Byung Ha Chung, Chul Woo Yang |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
The Korean Society of Nephrology
2021-09-01
|
סדרה: | Kidney Research and Clinical Practice |
נושאים: | |
גישה מקוונת: | http://www.krcp-ksn.org/upload/pdf/j-krcp-21-012.pdf |
פריטים דומים
-
HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies
מאת: Marc-Antoine Béland, et al.
יצא לאור: (2024-11-01) -
Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients
מאת: Patrizia Comoli, et al.
יצא לאור: (2022-11-01) -
Cost-Effectiveness of Rituximab Versus Bortezomib in Kidney Transplant Patients
מאת: Yadgar Rashidi, et al.
יצא לאור: (2024-05-01) -
Treatment of Antibody-Mediated Rejection in Kidney Transplantation
מאת: Magdalena Durlik
יצא לאור: (2013-07-01) -
Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
מאת: F Ahmadi, et al.
יצא לאור: (2019-07-01)